The utility of molecular testing in the recognition of undifferentiated metastatic melanoma

Leila Moayed-Alaei; Stephen C. Mann; Elizabeth C. Paver; Richard A Scolyer

doi:10.1016/j.pathol.2021.12.176

Related publications

Article2016

The molecular profile of metastatic melanoma in Australia

Megan Lyle, Lauren E. Haydu, Alexander M. Menzies, John F. Thompson, Robyn P.M. Saw, Andrew J. Spillane, Richard Kefford, Graham J. Mann, Wendy A. Cooper, Bing Yu, Richard A Scolyer, Sandra O’Toole, Georgina V. Long

Article2020

Mutational analysis of undifferentiated melanoma

Karina Aivazian, Robert V. Rawson, James S. Wilmott, Peter M. Ferguson, John F. Thompson, Georgina V. Long, Richard A Scolyer

Letter2022

Utility of next generation sequencing for differentiating malignant PEComa from metastatic melanoma

Elizabeth C. Paver, Karina Aivazian, Fiona Maclean, Georgina V. Long, Andrew J. Spillane, James S. Wilmott, Richard A Scolyer

Article2022

Pathologist initiated reflex BRAF mutation testing in metastatic melanoma: experience at a specialist melanoma treatment centre

Alison J. Potter, Andrew J. Colebatch, Robert V. Rawson, Peter M. Ferguson, Wendy A. Cooper, Ruta Gupta, Sandra O’Toole, Robyn P.M. Saw, Sydney Ch’ng, Alexander M. Menzies, Georgina V. Long, Richard A Scolyer

Article2016

Utility functions as aggregation functions in face recognition

Dolecki Michal, Paweł Karczmarek, Adam Kiersztyn, Witold Pedrycz